脂质纳米颗粒用于癌症免疫治疗中的mRNA输送
Yasir Alshehry1,2, Xiang Liu3, Wenhua Li3
1Department of Pharmaceutics, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, 23298, United States of America.
The AAPS journal
|March 19, 2025
概括
传递 RNA (mRNA) 脂质纳米粒子 (LNP) 正在彻底改变癌症免疫疗法. 本综述详细介绍了LNP的设计,交付和用于增强癌症治疗疗效的应用.
科学领域:
- 生物技术是生物技术.
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 癌症免疫疗法是主要的治疗方式.
- 使者RNA (mRNA) 疗法为癌症免疫治疗提供了一个有前途的平台.
- 有效的输送系统对于mRNA治疗疗效和安全至关重要.
研究的目的:
- 审查用于癌症免疫治疗的信使RNA (mRNA) 脂质纳米粒子 (LNP) 的进展.
- 探索LNP设计,表征和mRNA传递的结构-活动关系.
- 讨论影响LNP传染,向和热带的因素,并审查临床前/临床应用.
主要方法:
- 关于mRNA LNP开发的关键进展的文献综述.
- 分析LNP的化学结构,表征和结构-活性关系 (SAR).
- 讨论影响LNP性能的因素和临床前和临床应用的审查.
主要成果:
- 脂质纳米颗粒 (LNP) 在提供mRNA用于癌症免疫治疗方面取得了巨大成功.
- 优化的LNP增强了mRNA的稳定性,转染和细胞内传递.
- 在改善内体逃生和被动准效率方面仍然存在挑战.
结论:
- 载有mRNA的LNP对于推进癌症免疫疗法至关重要.
- 了解LNP设计和SAR是优化治疗结果的关键.
- 对LNP传递系统的持续研究将增强癌症治疗策略.
相关概念视频
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
02:15Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K